Groundbreaking New Drug Nearly Doubles Pancreatic Cancer Survival

A landmark clinical trial shows a new pancreatic cancer drug significantly improved survival rates in participants who'd been previously treated with chemotherapy. The success of the experimental pill, daraxonrasib, signifies a major breakthrough in pancreatic cancer treatment.

June 5, 2026   TODAY’S TOP STORY Groundbreaking New Drug Nearly Doubles Pancreatic Cancer Survival READ ON   Can You Eat Too Much Garlic? READ ON   10 Dietary Restrictions for Event Planners to Know About READ ON   Do Women Need More Sleep Than Men? READ ON MORE STORIES PRODUCT PICK Kitchen Kit: Family Must-Haves That Save You Time   Why waste money on tools you don't use? Our team shares the family kitchen essentials that are genuinely worth the investment and save you time. SHOP NOW TODAY'S RESOURCE Tame flare-ups — find psoriatic arthritis relief   Say goodbye to stiffness and pain, and hello to a stronger, healthier you. Learn how diet and exercise can tame flare-ups with our easy micro-lessons. SIGN UP NOW What we’re reading next • Do You Have a Pineapple Allergy? Learn the Symptoms • Common Underlying Conditions with Prurigo Nodularis • 10 Benefits of Drinking Hot Water • Statins for Cholesterol: Facts vs. Myths We'd love to hear from you! Send us a message at newsletters@healthline.com to let us know what else you’d like to see. Until then, Take care of yourself, and we’ll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy. Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Every product we recommend has gone through either Healthline’s or Optum Now’s vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health. © 2026 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707